Heng Xue

发表

Dendritic cell targeting virus-like particle delivers mRNA for in vivo immunization

Xin Eric Wang, Ze-Guang Han, T. Ying, 2021 .

Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19

Hang Yang, H. Wei, X. Qiao, 2022, Acta Pharmaceutica Sinica B.

Thermosensitive Hydrogel Wound Dressing Loaded with Bacteriophage Lysin LysP53

Hang Yang, H. Wei, Raphael Nyaruaba, 2022, Viruses.

Phage-bacterial evolutionary interactions: experimental models and complications

H. Wei, Xiaoxu Zhang, Dongyan Xiong, 2022, Critical reviews in microbiology.

Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection

H. Wei, H. Zhuang, X. Qiao, 2021, Journal of Advanced Research.

Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii

H. Wei, Hang Yang, Xiaoxu Zhang, 2022, Journal of bacteriology.

Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions.

Xinfeng Li, H. Wei, Hang Yang, 2023, The Journal of antimicrobial chemotherapy.

Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation

Hang Yang, H. Wei, Linjie Li, 2023, Journal of pharmaceutical analysis.

Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers.

Jiaxu Hong, Ruijiao Dong, W. Hong, 2024, Nature biomedical engineering.